Author: News Room

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) — The “Global Medical Equipment Maintenance Market Analysis & Forecast 2024-2034” report has been added to ResearchAndMarkets.com’s offering. The global medical equipment maintenance market is projected to experience a significant growth spurt, with expectations to ascend from USD 50.43 billion in 2023 to an estimated USD 163.09 billion by 2034, marking a Compound Annual Growth Rate (CAGR) of 11.26% during the forecast period from 2024 to 2034. This market expansion can be attributed to several critical factors, including the intensifying emphasis on preventive medical equipment maintenance, an upswing in technological advancements, and the increasing…

ANDOVER, Mass., Jan. 24, 2024 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that transform our world, is committed to developing, delivering, and scaling innovative, customer-focused products and services for the Photonics Industry. The MKS brands of the Photonics Solutions Division – Newport™, Ophir®, and Spectra-Physics® – have been a formidable market-leading force in the industry for decades and have had a constant presence at the SPIE Photonics West conference since its inception in 1995. At Photonics West 2024, San Francisco, CA, January 30 – February 1, 2024, MKS will highlight some of its new…

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) — The “Global RNA-based Therapeutics Market” report has been added to ResearchAndMarkets.com’s offering. The Global RNA-based Therapeutics Market was estimated at USD 13.83 billion in 2023 and is expected to reach USD 25.47 billion by 2034, witnessing a CAGR of 5.71% during the forecast period 2024-2034. The rising prevalence of chronic diseases, advancements in RNA technologies, growing adoption of personalized medicine, growing investment and funding, and collaborations between pharmaceutical companies will drive market growth. An Emerging Leader: Antisense Oligonucleotides Segment The report reveals that the antisense oligonucleotides segment currently leads the market in revenue,…

David Gerken Promoted to EVP | Chief Lending OfficerTim Carsey Promoted to SVP | Chief Administrative OfficerAlexis Smith Promoted to SVP | Chief People OfficerAmy Cover Promoted to SVP | Chief Marketing Officer ARCHBOLD, Ohio, Jan. 24, 2024 (GLOBE NEWSWIRE) — F&M Bank (“F&M”), an Archbold, Ohio based bank owned by Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO) today announced the retirements of Rex Rice, EVP & Chief Lending Officer and Benét Rupp, EVP & Chief Administrative Officer. Rice will remain in his role until March 1, 2024. Rupp will remain in her role until March 22, 2024. F&M also…

HOUSTON, Jan. 24, 2024 (GLOBE NEWSWIRE) — Crown Castle Inc. (NYSE: CCI) (“Crown Castle”) today reported results for the fourth quarter and full year ended December 31, 2023 and maintained its full year 2024 outlook, as reflected in the table below.  Full Year 2024 Full Year 2023(dollars in millions, except per share amounts)Current OutlookMidpoint(a)MidpointGrowth RateCompared toFull Year 2023Actual ActualActual GrowthRate Comparedto Full Year2022 Actual Site rental revenues$6,370(2)%  $6,5324% Net income (loss)$1,253(17)%  $1,502(10)% Net income (loss) per share—diluted$2.88(17)%  $3.46(10)% Adjusted EBITDA(b)$4,163(6)%  $4,4152% AFFO(b)$3,005(8)%  $3,2772% AFFO per share(b)$6.91(8)%  $7.552%  (a)   As issued on January 24, 2024 and unchanged from the previous full year 2024 Outlook issued on October 18, 2023.(b)  See “Non-GAAP Measures and Other Information” for further…

SOLANA BEACH, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) — ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced installation and completion of an initial procedure with both the ClearPoint Prism Neuro Laser Therapy System and the ClearPoint Neuro Navigation System by Dr. Jonathan Riley and team at Kaleida Health in Buffalo, New York. “We are ecstatic to have completed our first successful case with combined ClearPoint Neuro MRI targeting and laser ablation solutions,” stated Dr. Jonathan Riley, Assistant Professor of Neurosurgery at the University…

NEW YORK, Jan. 24, 2024 (GLOBE NEWSWIRE) — At the end of the settlement date of January 12, 2024, short interest in 3,156 Nasdaq Global MarketSM securities totaled 10,526,593,349 shares compared with 10,419,434,627 shares in 3,166 Global Market issues reported for the prior settlement date of December 29, 2023. The mid-January short interest represents 3.05 days compared with 2.60 days for the prior reporting period. Short interest in 1,726 securities on The Nasdaq Capital MarketSM totaled 2,003,311,075 shares at the end of the settlement date of January 12, 2024, compared with 1,955,740,100 shares in 1,717 securities for the previous reporting…

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) — The “Global CAR-T Cell Therapy Market Analysis & Forecast to 2024-2034” report has been added to ResearchAndMarkets.com’s offering. With the prevalence of cancer on the rise globally, innovative treatment methodologies are highly sought after. In this context, this market analysis and forecast for the global CAR-T cell therapy sector is a crucial development for stakeholders in the medical and biotechnological landscapes. As the sector embraces cutting-edge therapies, advancements in chimeric antigen receptor (CAR) T-cell therapy are drawing significant industry focus, with expectations of substantial growth over the next decade. The study brings a…

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) — The “Global Foot and Ankle Devices Market Analysis & Forecast 2024-2034” report has been added to ResearchAndMarkets.com’s offering. This comprehensive analysis of the global foot and ankle devices market forecasts significant growth from 2023 to 2034. The extensive market research provides insights into the current trends, growth drivers, and key segments influencing the market dynamics over the coming decade. The report estimates the global foot and ankle devices market size to achieve an impressive CAGR of 6.94% during the forecast period, with the market value anticipated to double from USD 4.58 billion in…

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) — The “Global Wearable Injectors Market Analysis & Forecast to 2024-2034” report has been added to ResearchAndMarkets.com’s offering. The global wearable injectors market size was estimated at USD 8.85 billion in 2023, projected to reach USD 55.84 billion by 2034 with a CAGR of 18.23% from 2024 to 2034. Key factors driving market growth include the increasing prevalence of chronic illnesses, a rising geriatric population, heightened concerns about needle stick injuries, growing demand for continuous monitoring and home-based treatment, robust healthcare infrastructure, an uptick in lifestyle disorders, surge in regulatory approvals, and strategic initiatives…